From: FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients
Estimate | CI | p | VIF | |
---|---|---|---|---|
Eye involvement | − 8.490 | − 19.15 to 2.17 | 0.118 | 1.16 |
Liver involvement | − 2.417 | − 15.76 to 10.92 | 0.721 | 1.48 |
Lung involvement | − 4.078 | − 13.58 to 5.42 | 0.398 | 1.08 |
Skin involvement | − 0.164 | − 8.73 to 8.40 | 0.970 | 1.04 |
CNS involvement | 2.077 | − 9.07 to 13.23 | 0.713 | 1.11 |
Renal involvement | − 0.448 | − 12.63 to 11.73 | 0.942 | 1.04 |
Heart involvement | − 4.250 | − 21.20 to 12.70 | 0.621 | 1.04 |
Bone involvement | − 23.064 | − 37.63 to − 8.49 | 0.002 | 1.06 |
Joint | − 12.889 | − 28.74 to 2.96 | 0.110 | 1.08 |
Spleen involvement | − 12.804 | − 28.66 to 3.05 | 0.113 | 1.43 |
BMI | − 1.076 | − 1.61 to − 0.54 | 0.0001 | 1.05 |
Male | − 5.803 | − 11.75 to 0.14 | 0.056 | 1.09 |
Age | − 0.004 | − 0.23 to 0.22 | 0.969 | 1.04 |